Welcome to LookChem.com Sign In|Join Free

CAS

  • or

176504-90-8

Post Buying Request

176504-90-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • tianfuchem-Carbamic acid,N-[(1S)-3-(dimethoxyphosphinyl)-2-oxo-1-(phenylmethyl)propyl]-,1,1-dimethylethyl ester

    Cas No: 176504-90-8

  • USD $ 3400.0-3400.0 / Metric Ton

  • 1 Metric Ton

  • 1 Metric Ton/Day

  • Henan Tianfu Chemical Co., Ltd.
  • Contact Supplier

176504-90-8 Usage

Chemical Properties

White powder

Check Digit Verification of cas no

The CAS Registry Mumber 176504-90-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,6,5,0 and 4 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 176504-90:
(8*1)+(7*7)+(6*6)+(5*5)+(4*0)+(3*4)+(2*9)+(1*0)=148
148 % 10 = 8
So 176504-90-8 is a valid CAS Registry Number.

176504-90-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-butyl N-[(2S)-4-dimethoxyphosphoryl-3-oxo-1-phenylbutan-2-yl]carbamate

1.2 Other means of identification

Product number -
Other names dimethyl (3S)-3-[(tert-butoxycarbonyl)amino]-2-oxo-4-phenylbutylphosphonate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:176504-90-8 SDS

176504-90-8Relevant articles and documents

Impact of stereochemistry on ligand binding: X-ray crystallographic analysis of an epoxide-based HIV protease inhibitor

Benedetti, Fabio,Berti, Federico,Campaner, Pietro,Fanfoni, Lidia,Demitri, Nicola,Olajuyigbe, Folasade M.,De March, Matteo,Geremia, Silvano

, p. 968 - 972 (2014)

A new pseudopeptide epoxide inhibitor, designed for irreversible binding to HIV protease (HIV-PR), has been synthesized and characterized in solution and in the solid state. However, the crystal structure of the complex obtained by inhibitor-enzyme cocrys

Synthesis and biological activity of potent HIV-1 protease inhibitors based on Phe-Pro dihydroxyethylene isosteres

Benedetti, Fabio,Berti, Federico,Budal, Sara,Campaner, Pietro,Dinon, Francesca,Tossi, Alessandro,Argirova, Radka,Genova, Petia,Atanassov, Vasil,Hinkov, Anton

experimental part, p. 3900 - 3910 (2012/07/28)

Peptidomimetic inhibitors of HIV-1 PR are still a key resource in the fight against AIDS. Here we describe the synthesis and biological activity of HIV-1 PR inhibitors based on four novel dihydroxyethylene isosteres of the Phe-Pro and Pro-Pro dipeptides. The isosteres, containing four stereogenic centers, were synthesized in high yield and excellent stereoselectivity via the cyclization of epoxy amines derived from α-amino acids. The inhibitors were assembled by coupling the isosteres with suitable flanking groups and were screened against recombinant HIV PR showing activities in the subnanomolar to micromolar range. Two Phe-Pro-based inhibitors active at the nanomolar level were further investigated: both inhibitors combine the ability to suppress HIV-1 replication in infected MT-2 cells with low cytotoxicity against the same cells, thereby displaying a high therapeutic index. These results demonstrate the potential of the new Phe-Pro dihydroxyethylene isostere as a core unit of powerful HIV-1 PR inhibitors.

Angiotensin I-converting enzyme (ace) inhibitors

-

Page/Page column 9, (2009/12/04)

This invention relates to a process for the synthesis of ketomethylene derivatives of the tripeptide Phe-Gly-Pro (“keto-ACE”, compound 5a) and analogues thereof. The synthesis process proceeds via an α,β-unsaturated keto intermediate. A key feature of the process involves a Horner-Emmons olefination of the, -unsaturated keto-phosphonate with ethyl glyoxylate. Keto-ACE analogues produced by the process of the invention display C-domain selectivity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 176504-90-8